SCHEMBL25162020

SCHEMBL25162020

CC(C)(C)Nc1ccc(CN2CCCN(CC(=O)O)CCN(CC(=O)O)CCCN(CC(=O)O)CC2)cc1

nearest known ligand 0.51

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.50
▸ KDM4E B2RXH2 1/20 0.50
▸ LMNA P02545 3/20 0.49
▸ RAB9A P51151 2/20 0.49
▸ NPC1 O15118 1/20 0.49
▸ TP53 P04637 1/20 0.49
▸ POLB P06746 1/20 0.49
▸ HRH3 Q9Y5N1 2/20 0.47
▸ LTA4H P09960 1/20 0.47
▸ ATM Q13315 1/20 0.45
▸ TNIK Q9UKE5 1/20 0.45
▸ MEN1 O00255 2/20 0.44
▸ KMT2A Q03164 2/20 0.44
▸ FAAH O00519 1/20 0.44
▸ MAPT P10636 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25161931 0.96 RAB9A (0.52) ALDH1A1KDM4ELMNARAB9ANPC1
SCHEMBL25162023 0.84 LMNA (0.42) ALDH1A1KDM4ELMNAMEN1KMT2A
SCHEMBL21965770 0.83 HRH3 (0.59) ALDH1A1KDM4EHRH3TNIKMEN1
SCHEMBL21965380 0.81 HRH3 (0.62) ALDH1A1KDM4EPOLBHRH3MEN1
SCHEMBL22815125 0.80 NPC1 (0.52) ALDH1A1KDM4ELMNARAB9ANPC1
SCHEMBL22361385 0.78 KDM4E (0.63) ALDH1A1KDM4ERAB9ANPC1TP53
SCHEMBL28777882 0.78 ALDH1A1 (0.66) ALDH1A1KDM4ELMNAATMMEN1
SCHEMBL18292063 0.78 KDM4E (0.63) ALDH1A1KDM4ERAB9ANPC1TP53
SCHEMBL18292042 0.78 KDM4E (0.63) ALDH1A1KDM4ERAB9ANPC1TP53
SCHEMBL25162041 0.78 FOLH1 (0.47) ALDH1A1LMNAMEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230121556-A1 COMPOUNDS FOR FAST AND EFFICIENT CLICK RELEASE TAGWORKS PHARMACEUTICALS B.V. (NL) 2023-04-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230121556-A1 COMPOUNDS FOR FAST AND EFFICIENT CLICK RELEASE LTB4R, LTC4S, LTA4H ALDH1A1 879/4885KDM4E 1583/4885LMNA 3805/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback